Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.

Autor: Kamath AV, Lu D, Gupta P, Jin D, Xin Y, Brady A, Stephan JP, Li H, Tien J, Qing J, Damico-Beyer LA
Zdroj: Cancer Chemotherapy & Pharmacology; Apr2012, Vol. 69 Issue 4, p1071-1078, 8p
Databáze: Complementary Index
Externí odkaz: